Preclinical Evaluation of Nilotinib Efficacy in an Imatinib-Resistant KIT-Driven Tumor Model
Carleen Cullinane, Anthony Natoli, Yorlon Hui, Nelly Conus, Susan Jackson, Joseph Brueggen, Paul W Manley, Grant A McArthur
Molecular Cancer Therapeutics | AMER ASSOC CANCER RESEARCH | Published : 2010
This work was supported by a grant to G.A. McArthur from Novartis Pharma.